Letters

I read with great interest your article on NIH researchers Walter Stewart and Ned Feder, who are investigating scientists for fraud and other misconduct. I think that the article did a good job in pointing out something quite different from what was intended, namely, the closed shop or “guild” mentality of the scientific community. The fact of the matter is that scientific research is a business, just like the music industry, the auto industry, or television repair. Witness J

Written byAvraham Sonenthai
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

I read with great interest your article on NIH researchers Walter Stewart and Ned Feder, who are investigating scientists for fraud and other misconduct.

I think that the article did a good job in pointing out something quite different from what was intended, namely, the closed shop or “guild” mentality of the scientific community.

The fact of the matter is that scientific research is a business, just like the music industry, the auto industry, or television repair. Witness James Wyngaarden’s statement: “Their scientific productivity has been extraordinarily low.” Research is a product, no different from any other.

However, this business is definitely not run in a professional manner. The sciences are rife with favoritism, politics, hype, egoism, and self-promotion. More than one career has been built on the backs of technicians and graduate students whe deserved coauthorship and were unethically locked out of it. And let’s not forget all the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies